Retracted: Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

Dis Markers. 2023 Jun 21:2023:9826032. doi: 10.1155/2023/9826032. eCollection 2023.

Abstract

[This retracts the article DOI: 10.1155/2022/2483816.].

Publication types

  • Retraction of Publication